[go: up one dir, main page]

HK1180594A - Compositions and methods for inhibiting expression of cd274/pd-l1 gene - Google Patents

Compositions and methods for inhibiting expression of cd274/pd-l1 gene Download PDF

Info

Publication number
HK1180594A
HK1180594A HK13107928.7A HK13107928A HK1180594A HK 1180594 A HK1180594 A HK 1180594A HK 13107928 A HK13107928 A HK 13107928A HK 1180594 A HK1180594 A HK 1180594A
Authority
HK
Hong Kong
Prior art keywords
compositions
gene
methods
inhibiting expression
dsrna
Prior art date
Application number
HK13107928.7A
Other languages
Chinese (zh)
Inventor
Antonin Defougerolles
Tatiana Novobrantseva
Brian Bettencourt
Original Assignee
Alnylam Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals, Inc. filed Critical Alnylam Pharmaceuticals, Inc.
Publication of HK1180594A publication Critical patent/HK1180594A/en

Links

Abstract

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the CD274/PD-L1 gene, and methods of using such dsRNA compositions to inhibit expression of CD274/PD-L.
HK13107928.7A 2010-04-06 2011-04-06 Compositions and methods for inhibiting expression of cd274/pd-l1 gene HK1180594A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/321,263 2010-04-06

Publications (1)

Publication Number Publication Date
HK1180594A true HK1180594A (en) 2013-10-25

Family

ID=

Similar Documents

Publication Publication Date Title
CA2792561C (en) Compositions and methods for inhibiting expression of cd274/pd-l1 gene
WO2013155204A3 (en) Compositions and methods for inhibiting expression of the alas1 gene
MX2018013216A (en) Compositions and methods for inhibiting expression of tmprss6 gene.
WO2012177947A3 (en) Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
WO2009129465A3 (en) Compositions and methods for inhibiting expression of xbp-1 gene
WO2012027713A3 (en) Compositions and methods for inhibition of snca
WO2009076400A3 (en) Compositions and methods for inhibiting expression of factor vii gene
WO2011139911A3 (en) Lipid formulated single stranded rna
WO2012177921A3 (en) Compositions and methods for inhibiting hepcidin antimicrobial peptide (hamp) or hamp-related gene expression
WO2013163430A3 (en) Serpinc1 irna compositions and methods of use thereof
WO2014160129A3 (en) Complement component c5 irna compositions and methods of use thereof
WO2010048228A3 (en) Compositions and methods for inhibiting expression of transthyretin
WO2011153323A3 (en) Compositions and methods directed to treating liver fibrosis
WO2011020023A3 (en) Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
WO2008121604A3 (en) Compositions and methods for inhibiting expression of a gene from the ebola
WO2012079046A3 (en) Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
WO2012018881A3 (en) Methods and compositions for the regulation of rna
WO2012006241A3 (en) Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
WO2011160052A3 (en) Methods and compositions for sequence specific rna endonucleases
PH12016500574A1 (en) Compositions and methods for inhibiting expression of the alas1 gene
WO2010006342A9 (en) Compositions and methods for inhibiting expression of gsk-3 genes
WO2011103028A3 (en) Compositions and methods for inhibiting mmset
IN2015DN02699A (en)
HK1180594A (en) Compositions and methods for inhibiting expression of cd274/pd-l1 gene
WO2009137128A3 (en) Compositions and methods for inhibiting expression of cd45 gene